Editor's Note: We're giving you special access to Bill's Private Briefing because spin-offs and deal making are minting new millionaires weekly. Companies are going out to buy growth, and they're bringing trillions of dollars off the sidelines as this niche explodes. Here's Bill...
We love spin-offs.
And it's not just because you were able to cash in on our recommendation of Abbott Laboratories Inc. (NYSE: ABT), whose subsequent breakup into two companies has so far resulted in gains of 27% and 47%.
We love spin-offs because, as a group, they offer high-probability opportunities for market-beating profits. Since the Abbott pick, we've issued reports on several other spin-off opportunities.
Our goal: To help you assemble a portfolio of these "special-situation" profit plays.
Here's the portfolio... Full Story